搜索临床试验以:cadonilimab (anti PD-1/CTLA-4 bispecific antibody)
总计62097个结果
-
Duke University终止
-
Sun Yat-sen UniversityChongqing University Cancer Hospital; Xiangya Hospital of Central South University; Tongji Hospital 和其他合作者招聘中
-
National Institute of Allergy and Infectious Diseases...完全的HIV-1 感染 | HIV抗体 | 中和抗体 | 病毒载量 | 单克隆抗体美国
-
Sun Yat-sen UniversityShanghai Junshi Bioscience Co., Ltd.主动,不招人
-
National Cancer Institute (NCI)完全的
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Chest Hospital未知化疗效果 | KRAS基因突变 | NSCLC IV期 | PD-1抗体
-
Genentech, Inc.完全的
-
Ottawa Hospital Research InstituteOntario Institute for Cancer Research尚未招聘
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Multiple Myeloma Research Foundation终止
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb完全的
-
Idera Pharmaceuticals, Inc.Bristol-Myers Squibb终止转移性黑色素瘤美国, 加拿大, 西班牙, 英国, 法国, 澳大利亚, 德国, 意大利, 荷兰, 瑞典, 捷克语
-
CytomX Therapeutics终止
-
Fuda Cancer Hospital, GuangzhouBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.撤销
-
Shanghai Cell Therapy Research Institute未知
-
National Cancer Institute (NCI)招聘中
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central Hospital撤销
-
Northwestern UniversityRobert H. Lurie Cancer Center完全的
-
Fudan UniversityShanxi Province Cancer Hospital; Inner Mongolia Cancer Hospital Affiliated To Inner Mongolia...招聘中
-
Sun Yat-sen UniversityGuangdong Provincial Hospital of Traditional Chinese Medicine; Fujian Cancer Hospital; Second... 和其他合作者招聘中
-
Huashan HospitalJiangsu HengRui Medicine Co., Ltd.; Shanghai Sunstem Biotechnology Co., Ltd.招聘中
-
Lei Li招聘中宫颈癌 | 免疫疗法 | 生存结果 | 不良事件 | 局部晚期宫颈癌 | 放化疗 | 免疫检查点抑制剂 | 抗程序性细胞死亡受体 1 | Early Stage Cervical Cancer中国
-
Sun Yat-sen UniversityFudan University; Liaoning Tumor Hospital & Institute主动,不招人
-
The First Affiliated Hospital of Zhengzhou University招聘中
-
Sun Yat-sen UniversityChongqing University Cancer Hospital; Jiangxi Provincial Cancer Hospital; Shenzhen People's Hospital 和其他合作者招聘中